Back to GILD
KBC Group NV GILD Position History
Gilead Sciences, Inc. • Healthcare
Quarters held
15
Latest value
$4.4M
Q3 2026
Peak value
$391.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $37K |
| Q3 2025 | $322.6M |
| Q3 2025 | $6M |
| Q4 2025 | $41K |
| Q4 2025 | $391.2M |
| Q4 2025 | $7M |
| Q1 2026 | $47K |
| Q1 2026 | $366.1M |
| Q1 2026 | $7.3M |
| Q2 2026 | $43K |
| Q2 2026 | $202.5M |
| Q2 2026 | $5.2M |
| Q3 2026 | $108K |
| Q3 2026 | $207.1M |
| Q3 2026 | $4.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4.4M | 29.3K | — | — |
| Q3 2026 | $207.1M | 1.39M | — | — |
| Q3 2026 | $108K | 723 | — | — |
| Q2 2026 | $5.2M | 40.9K | — | — |
| Q2 2026 | $202.5M | 1.60M | — | — |
| Q2 2026 | $43K | 337 | — | — |
| Q1 2026 | $7.3M | 52.4K | — | — |
| Q1 2026 | $366.1M | 2.63M | — | — |
| Q1 2026 | $47K | 337 | — | — |
| Q4 2025 | $7M | 56.9K | — | — |
| Q4 2025 | $391.2M | 3.19M | — | — |
| Q4 2025 | $41K | 337 | — | — |
| Q3 2025 | $6M | 54.4K | — | — |
| Q3 2025 | $322.6M | 2.91M | — | — |
| Q3 2025 | $37K | 337 | — | — |
Other funds holding GILD
$13.3B
$12.5B
$12.5B
$11.9B
$8.3B
$7.7B
$7.7B
$7.4B